AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 >>
Results: 51-75/100

Authors: EMMERICH F BARGOU RC KRAPPMANN D BOMMERT K GREINER A SCHEIDEREIT C DORKEN B
Citation: F. Emmerich et al., NF-KAPPA-B ACTIVATION REQUIRED FOR PROLIFERATION AND APOPTOSIS-RESISTANCE OF HODGKINS-DISEASE TUMOR-CELLS, Blood, 90(10), 1997, pp. 1729-1729

Authors: DANIEL PT RITSCHEL S BROWN R PEZZUTTO A KOHNE CH DORKEN B
Citation: Pt. Daniel et al., BIK NBK-1, AN APOPTOSIS PROMOTING MEMBER OF THE BCL-2 FAMILY, INCREASES DRUG-SENSITIVITY MATURE T-LEUKEMIA-CELLS/, Blood, 90(10), 1997, pp. 2198-2198

Authors: WESTERMANN J HOPFER O AICHER A ZENKE M DORKEN B PEZZUTTO A
Citation: J. Westermann et al., MANNOSE-RECEPTOR MEDIATED GENE-TRANSFER IN HUMAN DENDRITIC CELLS, Blood, 90(10), 1997, pp. 2453-2453

Authors: KARAWAJEW L KOSSER A RUPPERT V MARTIN M SCHRAPPE M DORKEN B LUDWIG WD
Citation: L. Karawajew et al., CAPABILITY OF IL-7 TO PREVENT IN-VITRO SPONTANEOUS APOPTOSIS OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) CELLS CORRELATES WITH A CORTICAL MATURE PHENOTYPE AND A GOOD INITIAL IN-VIVO RESPONSE TO CHEMOTHERAPY/, Blood, 90(10), 1997, pp. 2493-2493

Authors: MAPARA MY KORNER IJ HILDEBRANDT M BARGOU R KRAHL D REICHARDT P DORKEN B
Citation: My. Mapara et al., MONITORING OF TUMOR-CELL PURGING AFTER HIGHLY EFFICIENT IMMUNOMAGNETIC SELECTION OF CD34 CELLS FROM LEUKAPHERESIS PRODUCTS IN BREAST-CANCERPATIENTS - COMPARISON OF IMMUNOCYTOCHEMICAL TUMOR-CELL STAINING AND REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION, Blood, 89(1), 1997, pp. 337-344

Authors: CAYEUX S BECK C DORKEN B BLANKENSTEIN T
Citation: S. Cayeux et al., COEXPRESSION OF INTERLEUKIN-4 AND B7.1 IN MURINE TUMOR-CELLS LEADS TOIMPROVED TUMOR REJECTION AND VACCINE EFFECT COMPARED TO SINGLE-GENE TRANSFECTANTS AND A CLASSICAL ADJUVANT, Human gene therapy, 7(4), 1996, pp. 525-529

Authors: PECHER G SPAHN G ZIEGNER M DORKEN B
Citation: G. Pecher et al., MUC1-CDNA-TRANSFECTED DENDRITIC CELLS AS TUMOR VACCINE, Experimental hematology, 24(9), 1996, pp. 185-185

Authors: BARGOU RC WAGENER C BOMMERT K ARNOLD W DANIEL PT MAPARA MY GRINSTEIN E ROYER HD DORKEN B
Citation: Rc. Bargou et al., BLOCKING OF TRANSCRIPTION FACTOR E2F DP BY DOMINANT-NEGATIVE MUTANTS IN A NORMAL BREAST EPITHELIAL-CELL LINE EFFICIENTLY INHIBITS APOPTOSISAND INDUCES TUMOR-GROWTH IN SCID MICE/, The Journal of experimental medicine, 183(3), 1996, pp. 1205-1213

Authors: WAGENER C BARGOU RC DANIEL PT BOMMERT K MAPARA MY ROYER HD DORKEN B
Citation: C. Wagener et al., INDUCTION OF THE DEATH-PROMOTING GENE BAX-ALPHA SENSITIZES CULTURED BREAST-CANCER CELLS TO DRUG-INDUCED APOPTOSIS, International journal of cancer, 67(1), 1996, pp. 138-141

Authors: LUBBE AS BERGEMANN C RIESS H SCHRIEVER F REICHARDT P POSSINGER K MATTHIAS M DORKEN B HERRMANN F GURTLER R HOHENBERGER P HAAS N SOHR R SANDER B LEMKE AJ OHLENDORF D HUHNT W HUHN D
Citation: As. Lubbe et al., CLINICAL-EXPERIENCES WITH MAGNETIC DRAG TARGETING - A PHASE-I STUDY WITH 4'-EPIDOXORUBICIN IN 14 PATIENTS WITH ADVANCED SOLID TUMORS, Cancer research, 56(20), 1996, pp. 4686-4693

Authors: BOMMERT K RICKERS A MAPARA MY DORKEN B
Citation: K. Bommert et al., IDENTIFICATION OF CELL-DEATH ASSOCIATED GENES AFTER INDUCTION OF APOPTOSIS BY SURFACE IGM CROSS-LINKING IN THE HUMAN BURKITT-LYMPHOMA CELL-LINE BL41, Blood, 88(10), 1996, pp. 3450-3450

Authors: DANIEL PT KROIDL A LANGNER K KOHNE CH DORKEN B
Citation: Pt. Daniel et al., INDUCTION OF THE CD95 (FAS APO-1) LIGAND - AN ALTERNATIVE MECHANISM IN CYTOSTATIC DRUG-INDUCED APOPTOSIS WHICH IS ACTIVE IN T-LYMPHOID BUT NOT B-LYMPHOID AND BREAST-CANCER CELLS/, Blood, 88(10), 1996, pp. 262-262

Authors: DANIEL PT HEMPEL C BOMMERT K BARGOU RC MAPARA MY DORKEN B
Citation: Pt. Daniel et al., TRIGGERING OF THE B-CELL ANTIGEN RECEPTOR PREVENTS CD95 (APO-1 FAS) MEDIATED APOPTOSIS OF CD40 LIGAND-ACTIVATED B-CELLS/, Blood, 88(10), 1996, pp. 640-640

Authors: WESTERMANN J AICHER A FISHER C DOHNER H MAPARA M DORKEN B PEZZUTTO A
Citation: J. Westermann et al., USE OF DENDRITIC CELLS (DC) FOR THE INDUCTION OF ANTI BCR-ABL IMMUNITY IN CHRONIC MYELOID-LEUKEMIA - SUPERIORITY OF CD34-DERIVED DC, Blood, 88(10), 1996, pp. 908-908

Authors: MAPARA MY KORNER IJ HILDEBRANDT M BARGOU R DORKEN B
Citation: My. Mapara et al., COMBINED POSITIVE AND NEGATIVE PURGING OF PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS IN BREAST-CANCER PATIENTS, Blood, 88(10), 1996, pp. 992-992

Authors: CAYEUX S RICHTER G NOFFZ G DORKEN B BLANKENSTEIN T
Citation: S. Cayeux et al., INFLUENCE OF GENE MODIFIED (IL-7, IL-4 AND B7) TUMOR-CELL VACCINES ONTUMOR-ANTIGEN PRESENTATION, Blood, 88(10), 1996, pp. 1090-1090

Authors: WESTERMANN J AICHER A QUIN Z CAYEUX S DAEMEN K BLANKENSTEIN T DORKEN B PEZZUTTO A
Citation: J. Westermann et al., IL-7 SECRETING, GENE MODIFIED DENDRITIC CELLS DISPLAY IMPROVED T-CELLSTIMULATORY ABILITY, Blood, 88(10), 1996, pp. 1236-1236

Authors: BARGOU RC EMMERICH F KRAPPMANN D BOMMERT K MAPARA MY ARNOLD W ROYER HD SCHEIDEREIT C DORKEN B
Citation: Rc. Bargou et al., BLOCKING OF NF-KAPPA-B BY DOMINANT-NEGATIVE IKB-ALPHA MUTANT IN THE HODGKIN CELL-LINE HD-MYZ REDUCES CELL-CYCLE PROGRESSION, PROMOTES APOPTOSIS AND SUPPRESSES TUMOR-GROWTH IN SCID MICE, Blood, 88(10), 1996, pp. 1527-1527

Authors: SCHOTT G SPERLING C SCHRAPPE M RATEI R MARTIN M MEYER U DORKEN B RIEHM H LUDWIG WD
Citation: G. Schott et al., T-CELL RECEPTOR (TCR) GAMMA-DELTA-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (T-ALL) - A SUBGROUP WITH DISTINCT IMMUNOPHENOTYPIC AND CLINICAL-FEATURES( T), Blood, 88(10), 1996, pp. 1793-1793

Authors: KARAWAJEW L WUCHTER C RUPPERT V DORKEN B LUDWIG WD
Citation: L. Karawajew et al., DIFFERENTIAL SUSCEPTIBILITY TO CD95-INDUCED APOPTOSIS IN ACUTE MYELOID-LEUKEMIA (AML) - DEPENDENCE ON CD34-PHENOTYPE AND GROWTH-CHARACTERISTICS IN-VITRO, Blood, 88(10), 1996, pp. 2240-2240

Authors: BARGOU RC LENG C KRAPPMANN D EMMERICH F MAPARA MY BOMMERT K ROYER HD SCHEIDEREIT C DORKEN B
Citation: Rc. Bargou et al., HIGH-LEVEL NUCLEAR NF-KAPPA-B AND OCT-2 IS A COMMON FEATURE OF CULTURED HODGKIN REED-STERNBERG CELLS/, Blood, 87(10), 1996, pp. 4340-4347

Authors: BECK C CAYEUX S LUPTON SD DORKEN B BLANKENSTEIN T
Citation: C. Beck et al., THE THYMIDINE KINASE GANCICLOVIR-MEDIATED SUICIDE EFFECT IS VARIABLE IN DIFFERENT TUMOR-CELLS, Human gene therapy, 6(12), 1995, pp. 1525-1530

Authors: REICHARDT P LENTZSCH S HOHENBERGER P DORKEN B
Citation: P. Reichardt et al., SUCCESSFUL AGGRESSIVE CHEMOTHERAPY IN PATIENTS WITH CHONDROSARCOMA - A REPORT OF 4 CASES, European journal of cancer, 31A, 1995, pp. 869-869

Authors: BARGOU RC BOMMERT K MAPARA MY DANIEL PT DORKEN B
Citation: Rc. Bargou et al., CONSTITUTIVE NUCLEAR-BINDING ACTIVITY OF NF-KAPPA-B AND OCT-2 ARE A COMMON AND SPECIFIC FEATURE OF CULTURED AND PRIMARY HODGKIN CELLS, Experimental hematology, 23(8), 1995, pp. 780-780

Authors: DANIEL PT MAPARA MY BOMMERT K BARGOU RC KRAMMER P DORKEN B
Citation: Pt. Daniel et al., CD95 (APO-1 FAS) AND THE CD95 LIGAND IN NORMAL AND MALIGNANT B-CELL APOPTOSIS/, Experimental hematology, 23(8), 1995, pp. 831-831
Risultati: 1-25 | 26-50 | 51-75 | 76-100 >>